Commonwealth Equity Services’s Lifecore Biomedical LFCR Stock Holding History

Commonwealth Equity Services’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-12,719	Closed	-$183K	–	2764
2018 Q3	$183K	Sell	12,719 -1,070	-8%	-$14.8K	﹤0.01%	2523
2018 Q2	$205K	Hold	13,789	–	–	﹤0.01%	2445
2018 Q1	$179K	Hold	13,789	–	–	﹤0.01%	2436
2017 Q4	$174K	Hold	13,789	–	–	﹤0.01%	2415
2017 Q3	$179K	Hold	13,789	–	–	﹤0.01%	2320
2017 Q2	$205K	Sell	13,789 -4,411	-24%	-$61.4K	﹤0.01%	2211
2017 Q1	$218K	Buy	+18,200	New	+$230K	﹤0.01%	2085

Other funds holding LFCR

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

ICOM

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

Walthausen & Co Malta, New York $120M AUM 2.66% 1-Year Est. Return

Commonwealth Equity Services's LFCR Position: Q4 2018 in Review

Commonwealth Equity Services sold out of Lifecore Biomedical (LFCR) in Q4 2018, closing a stake of 12,719 shares — an estimated $183K sold.

Commonwealth Equity Services first reported a position in LFCR in Q1 2017 and held it in 7 quarters. The position peaked at $218K in Q1 2017. 89 funds tracked by Wall St. Rank hold LFCR as of Q4 2018.

Commonwealth Equity Services reported no remaining Lifecore Biomedical position as of Q4 2018 after selling out during the quarter.
Commonwealth Equity Services sold 12,719 Lifecore Biomedical shares in Q4 2018, an estimated $183K.
Commonwealth Equity Services first reported a position in Lifecore Biomedical in Q1 2017 and held it in 7 quarters.
Commonwealth Equity Services's Lifecore Biomedical position peaked at $218K in Q1 2017.
89 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2018.

Based on Commonwealth Equity Services's 13F filing for Q4 2018, filed 11 Feb 2019.